๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

In vivo potentiation of cis-diamminedichloroplatinum (II) antitumor activity by pretreatment with sparsomycin

โœ Scribed by Zylicz, Zbigniew; Theo Wagener, D.J.; van Rennes, Helga; Wessels, Johannes M.C.; van der Kleijn, Eppo; de Grip, Willem J.; Ottenheijm, Harry C.J.; van den Broek, Leon A.G.M.

Book ID
123390297
Publisher
Elsevier Science
Year
1986
Tongue
English
Weight
450 KB
Volume
32
Category
Article
ISSN
0304-3835

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Ex vivo activated memory t-lymphocytes a
Ex vivo activated memory t-lymphocytes as adoptive cellular therapy of human soft-tissue sarcoma targets with potentiation by Cis-diamminedichloroplatinum (II)
โœ Jay E. Gold; Ted R. Masters; Norman D. Bloom; Michail K. Shafir; Michael J. Klei ๐Ÿ“‚ Article ๐Ÿ“… 1995 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 959 KB

specificity in one patient. Restriction of ALT-cell lysis and IFN-y release against HLA-A2+ autologous and one allogeneic HLA-A2+ STS tumor target, but not other non-STS targets, was demonstrated in another patient. These data suggest that CDDP may help render STS susceptible to tumorspecific, immun

Adoptive cellular therapy of human breas
Adoptive cellular therapy of human breast and colorectal tumor targets using ex vivo activated memory T lymphocytes with potentiation by cis-diamminedichloroplatinum(II)
โœ Dr. Jay E. Gold; Ira J. Bleiweiss; Alisan B. Goldfarb; Joel J. Bauer; Irwin M. G ๐Ÿ“‚ Article ๐Ÿ“… 1994 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 677 KB

Autolymphocyte therapy (ALT) is adoptive cellular therapy of cancer using ex vivo activation of autologous peripheral blood lymphocytes (PBL). Memory T cells are the principal effector population in ALT, with in vivo activity in patients with metastatic renal cell carcinoma (RCC) and melanoma, and e